Amphiphilic Acyclic Cucurbit[n]uril: Synthesis, Self-Assembly, and Chemotherapeutic Delivery to Overcome Multidrug Resistance.

IF 4.5 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Molecular Pharmaceutics Pub Date : 2025-04-07 Epub Date: 2025-02-26 DOI:10.1021/acs.molpharmaceut.5c00012
Zizhen Zhao, Danying Ma, Shuyi Wang, Wei Zhou, Dan-Wei Zhang, Zhan-Ting Li, Da Ma
{"title":"Amphiphilic Acyclic Cucurbit[<i>n</i>]uril: Synthesis, Self-Assembly, and Chemotherapeutic Delivery to Overcome Multidrug Resistance.","authors":"Zizhen Zhao, Danying Ma, Shuyi Wang, Wei Zhou, Dan-Wei Zhang, Zhan-Ting Li, Da Ma","doi":"10.1021/acs.molpharmaceut.5c00012","DOIUrl":null,"url":null,"abstract":"<p><p>A new amphiphilic acyclic cucurbit[<i>n</i>]uril (CB[<i>n</i>]) is designed and synthesized. This amphiphilic acyclic CB[<i>n</i>] could encapsulate pharmaceutical drugs via a host-guest interaction. Self-assembly of this acyclic CB[<i>n</i>] forms spherical nanoparticles with diameters of 91 nm in water. The self-assembled nanoparticles are capable of delivering doxorubicin with high efficiency. Cell experiments show that the doxorubicin-loaded nanoparticles can improve cellular uptake and cytotoxicity by using the MCF-7/ADR cell line. The A549 tumor-bearing mouse model shows that self-assembled nanoparticles help overcome multidrug resistance in vivo. Cell study and histological assays confirm the biocompatibility of self-assembled nanoparticles.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":"2259-2265"},"PeriodicalIF":4.5000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.5c00012","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

A new amphiphilic acyclic cucurbit[n]uril (CB[n]) is designed and synthesized. This amphiphilic acyclic CB[n] could encapsulate pharmaceutical drugs via a host-guest interaction. Self-assembly of this acyclic CB[n] forms spherical nanoparticles with diameters of 91 nm in water. The self-assembled nanoparticles are capable of delivering doxorubicin with high efficiency. Cell experiments show that the doxorubicin-loaded nanoparticles can improve cellular uptake and cytotoxicity by using the MCF-7/ADR cell line. The A549 tumor-bearing mouse model shows that self-assembled nanoparticles help overcome multidrug resistance in vivo. Cell study and histological assays confirm the biocompatibility of self-assembled nanoparticles.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
两亲性无环葫芦[n]uril:合成、自组装和化疗递送以克服多药耐药。
设计并合成了一种新的两亲性无环葫芦[n]uril (CB[n])。这种两亲性无环CB[n]可以通过主客体相互作用封装药物。这种无环CB[n]在水中自组装形成直径为91 nm的球形纳米颗粒。自组装的纳米颗粒能够高效地递送阿霉素。细胞实验表明,负载多柔比星的纳米颗粒可以改善MCF-7/ADR细胞株的细胞摄取和细胞毒性。A549荷瘤小鼠模型表明,自组装纳米颗粒有助于克服体内多药耐药。细胞研究和组织学分析证实了自组装纳米颗粒的生物相容性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
期刊最新文献
Issue Editorial Masthead Issue Publication Information Voices in Molecular Pharmaceutics: Meet Dr. Kristian Beran, a Pharmaceutical Scientist Bridging Science and Business Voices in Molecular Pharmaceutics: Meet Dr. Yutaka Maeda, Who Pioneers New Therapies to Treat Lung Disease Panax ginseng-derived Exosome-like Nanoparticles Prevent LPS-induced Septic Shock by Modulating TLR4 Glycosylation in Macrophages
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1